The Top 5 Biosimilar Articles for the Week of October 18

October 22, 2021

Here are the top 5 biosimilar articles for the week of October 18, 2021.

Amgen Executive Discusses Prominent Biosimilar Trends
Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars
Study: Basaglar "Biosimilar" Had Strong Downward Effect on Insulin Glargine Prices
Specialty Biologics Report Predicts Rise in Biosimilar Access